GlassScriptPhysician profile
Donna Zambuto
NPI 1790776169
$1,829.81
in general payments reported to CMS, 2019-2025
23 companies · $374 in 2025
The $374 reported for 2025 was more than what 89% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $79.42 · 2021: $305 · 2022: $267 · 2023: $357 · 2024: $323 · 2025: $374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,054.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,054.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $308.47 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $202.04 | 2019-2025 | Gardasil 9, Vaxelis, Vaqta |
| Kaleo, INC. | $185.03 | 2019-2024 | Auvi-Q |
| Verrica Pharmaceuticals INC. | $133.73 | 2023-2025 | Ycanth |
| Seqirus USA INC | $118.81 | 2021-2025 | Flucelvax, Flucelvax Quadrivalent |
| Takeda Pharmaceuticals U.S.A., INC. | $107.61 | 2020-2022 | |
| Glaxosmithkline, LLC. | $105.40 | 2019-2023 | Bexsero |
| Supernus Pharmaceuticals, INC. | $104.30 | 2021-2025 | Qelbree |
| Corium, LLC | $86.56 | 2023-2024 | Azstarys |
| Teva Pharmaceuticals USA, INC. | $62.76 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $60.64 | 2021-2023 | Flumist Quadrivalent |
| Collegium Pharmaceutical, INC. | $56.78 | 2025 | Jornay Pm |
| Sanofi-Aventis U.S. LLC | $51.78 | 2024-2025 | |
| Alk-Abello, INC | $44.06 | 2025 | Neffy |
| Hologic Sales and Service, LLC | $43.06 | 2025 | Aptima, Thinprep 2000 Processor |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $37.96 | 2024 | Doc Band |
| Alexion Pharmaceuticals, INC. | $27.81 | 2025 | Koselugo |
| Sanofi Pasteur INC. | $21.87 | 2025 | |
| Tris Pharma INC | $17.07 | 2021 | |
| Ironshore Pharmaceuticals INC. | $14.69 | 2020 | |
| Avion Pharmaceuticals | $13.77 | 2019 | |
| Shire North American Group INC | $13.22 | 2019 | |
| Sobi, INC | $12.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Zambuto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.